Elevation of regulatory T Cells in Adults with CF receiving Elexacaftor/Tezacaftor/Ivacaftor Therapy

被引：0
|
作者：
Westhoelter, D. [1 ]
Ubner, H. [1 ]
Raspe, J. [1 ]
Schmitz, M. [2 ,3 ]
Ngoc, Tran L. [1 ]
Strassburg, S. [1 ]
Welsner, M. [1 ]
Sutharsan, S. [1 ]
Taube, C. [1 ]
Reuter, S. [1 ]
机构：
[1] Univ Med Essen, Ruhrlandklin, Klin Pneumol, Essen, Germany
[2] Univ Med Essen, Ruhrlandklin, Essen, Germany
[3] Univ Med Essen, Expt Pneumol, Klin Pneumol, Ruhrlandklin,Klin Pneumol, Essen, Germany
来源：
PNEUMOLOGIE | 2023年 / 77卷
关键词：
D O I：
10.1055/s-0043-1760882
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
FV 47
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [31] Elexacaftor-Tezacaftor-Ivacaftor Therapy for Chronic Sinus Disease in Cystic Fibrosis
    Sheikh, Shahid
    Ho, Mai-Lan
    Eisner, Mariah
    Gushue, Courtney
    Paul, Grace
    Holtzlander, Melissa
    Johnson, Terri
    McCoy, Karen S.
    Lind, Meredith
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2023, 149 (12) : 1075 - 1082
  • [32] Unveiling the psychosocial impact of Elexacaftor/Tezacaftor/Ivacaftor therapy in Cystic Fibrosis patients
    Garcia, Marta Solis
    Pelaez, Adrian
    Punter, Rosa Mar Gomez
    Lopez, Maria Criado
    Carbajal, Claudia Madrid
    Ancochea, Julio
    Bachiller, Jose Maria Eiros
    Hernandez, Ana Sofia Martin
    Rodrigo-Garcia, Maria
    Clemente, Marta Garcia
    Moreno, Rosa Ma Giron
    BMC PULMONARY MEDICINE, 2025, 25 (01):
  • [33] 'Triple therapy' (elexacaftor, tezacaftor, ivacaftor) skin rash in patients with cystic fibrosis
    Hu, May Khei
    Wood, Genna
    Dempsey, Owen
    POSTGRADUATE MEDICAL JOURNAL, 2022, 98 (1156) : 86 - 86
  • [34] Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome
    Pallenberg, Sophia T.
    Pust, Marie-Madlen
    Rosenboom, Ilona
    Hansen, Gesine
    Wiehlmann, Lutz
    Dittrich, Anna-Maria
    Tummler, Burkhard
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [35] Measuring the effect of elexacaftor/tezacaftor/ivacaftor combination therapy on the respiratory pump in people with CF using dynamic chest radiography
    FitzMaurice, Thomas S.
    McCann, Caroline
    Nazareth, Dilip
    Shaw, Matthew
    McNamara, Paul S.
    Walshaw, Martin J.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (06) : 1036 - 1041
  • [36] Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
    Piehler, Linus
    Thalemann, Ralf
    Lehmann, Christine
    Thee, Stephanie
    Roehmel, Jobst
    Syunyaeva, Zulfiya
    Stahl, Mirjam
    Mall, Marcus A.
    Graeber, Simon Y.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [37] ELEXACAFTOR/TEZACAFTOR/IVACAFTOR MARKEDLY REDUCES SPUTUM PATHOGEN DENSITY IN PEOPLE WITH CF; A PROMISE STUDY
    Nichols, D. P.
    Morgan, S. J.
    Singh, S. B.
    Rowe, S.
    Hoffman, L.
    Singh, P.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S220 - S220
  • [38] Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis
    Marsh, Ryan
    Dos Santos, Claudio
    Yule, Alexander
    Dellschaft, Neele S.
    Hoad, Caroline L.
    Ng, Christabella
    Major, Giles
    Smyth, Alan R.
    Rivett, Damian
    van der Gast, Christopher
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (05) : 967 - 976
  • [39] Introduction of Elexacaftor-Tezacaftor-Ivacaftor therapy is associated with reduced enteral feeding
    Loel, Felicity
    Matson, Angela
    Herd, Karen
    Smith, Daniel
    RESPIROLOGY, 2024, 29 : 5 - 6
  • [40] Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis
    Steinack, Carolin
    Ernst, Matthias
    Beuschlein, Felix
    Hage, Rene
    Roeder, Maurice
    Schuurmans, Mace M.
    Schmid, Christoph
    Gaisl, Thomas
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (04) : 722 - 729
12345